» Authors » Nima Montazeri-Najafabady

Nima Montazeri-Najafabady

Explore the profile of Nima Montazeri-Najafabady including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 185
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bayat M, Koohpeyma F, Montazeri-Najafabady N, Dabbaghmanesh M, Asmarian N, Hosseini S
Int Urol Nephrol . 2024 Nov; 57(4):1123-1133. PMID: 39592499
Background: Diabetes mellitus is a widely distributed endocrine disorder in the world. Altered reproductive function is a notable long-term consequence of type 1 diabetes mellitus (T1DM). In the current study,...
2.
Karimi F, Montazeri-Najafabady N, Mohammadi F, Azadi A, Koohpeyma F, Gholami A
Nutr Diabetes . 2024 Aug; 14(1):66. PMID: 39164243
Background: The probiotic potential of Lacticacid bacteria has been studied in various medical complications, from gastrointestinal diseases to antibiotic resistance infections recently. Moreover, diabetic ulcer (DU) is known as one...
3.
Montazeri-Najafabady N, Dabbaghmanesh M
Biochem Genet . 2024 Jun; PMID: 38834820
Osteoporosis is a common disorder with a strong genetic component. Bone mineral density (BMD), vitamin D, and calcium levels declining are a main contributor of osteoporosis and fragility fractures. This...
4.
Koohpeyma F, Khodaparast Z, Salehi S, Danesh S, Gheshlagh F, Naseri A, et al.
BMC Complement Med Ther . 2024 May; 24(1):200. PMID: 38778296
Background: This study investigated the effect of curcumin nanomicelle (CUR-n) on the structure of testis tissue, the process of spermatogenesis, LH, FSH, testosterone, and oxidative stress in a model of...
5.
Nemati M, Ebrahimi B, Montazeri-Najafabady N
Genes Nutr . 2024 Mar; 19(1):7. PMID: 38504163
Probiotics has offered a new prospect to treat and manage a variety of endocrine disorders such as obesity, diabetes, non- alcoholic fatty liver disease and metabolic syndrome. The precise mechanisms...
6.
Gholami A, Montazeri-Najafabady N, Karimzadeh I, Dabbaghmanesh M, Talei E
BMC Pediatr . 2024 Jan; 24(1):54. PMID: 38233797
The increasing prevalence of metabolic syndrome, type 2 diabetes, and insulin resistance are driven by complex interactions between genetic and environmental factors. One of the single nucleotide polymorphisms (SNPs) in...
7.
Gholami A, Montazeri-Najafabady N, Ashoori Y, Kazemi K, Heidari R, Omidifar N, et al.
BMC Complement Med Ther . 2023 Jul; 23(1):243. PMID: 37461012
Background: Chronic kidney disease (CKD) is a worldwide public health problem affecting millions of people. Probiotics and postbiotics are associated with valuable compounds with antibacterial, anti-inflammatory, and immunomodulatory effects, preserving...
8.
Rezaei R, Moazamian E, Montazeri-Najafabady N
Mol Biol Rep . 2023 Apr; 50(5):4469-4480. PMID: 37014571
Background: Parasporin (PS) proteins have cytocidal activity preferential for various human malignant cells. The purpose of this investigation was to see if the PS separated from B. thuringiensis strain E8...
9.
Montazeri-Najafabady N, Dabbaghmanesh M, Asmarian N, Pour H
Int J Endocrinol . 2023 Mar; 2023:9143234. PMID: 36876280
Childhood dyslipidemia is considered a major worldwide health issue. Identification of children with dyslipidemia is notably essential for healthcare providers in establishing and releasing recommendations for the management and prevention...
10.
Gholami A, Dabbaghmanesh M, Ghasemi Y, Koohpeyma F, Talezadeh P, Montazeri-Najafabady N
BMC Complement Med Ther . 2022 Sep; 22(1):241. PMID: 36115982
Background: Osteoporosis, a skeletal disease described by impaired bone strength, cause an increased risk of fractures. We aimed in this study to clarify which particular wise combination of probiotics has...